CD 15 Test
New
2,600.00₹
In stock
All over India
0 Reviews
The CD15 test is a diagnostic laboratory evaluation used in hematopathology to detect expression of the CD15 cell-surface carbohydrate antigen (3-fucosyl-N-acetyllactosamine). Expressed prominently on mature neutrophils, eosinophils, and monocytes, CD15 serves as an important marker in immunophenotyping.
Conducted via immunohistochemistry or flow cytometry on blood, bone marrow, or tissue biopsies, this test is critical for diagnosing Classical Hodgkin Lymphoma, where CD15 is typically positive on characteristic Reed-Sternberg cells. It also aids in identifying granulocytic differentiation in Acute Myeloid Leukemia (AML). Evaluating CD15 expression assists clinicians in accurate cancer subtyping, staging, and determining optimal targeted therapies.
Conducted via immunohistochemistry or flow cytometry on blood, bone marrow, or tissue biopsies, this test is critical for diagnosing Classical Hodgkin Lymphoma, where CD15 is typically positive on characteristic Reed-Sternberg cells. It also aids in identifying granulocytic differentiation in Acute Myeloid Leukemia (AML). Evaluating CD15 expression assists clinicians in accurate cancer subtyping, staging, and determining optimal targeted therapies.
The CD15 test is a diagnostic laboratory evaluation used in hematopathology to detect expression of the CD15 cell-surface carbohydrate antigen (3-fucosyl-N-acetyllactosamine). Expressed prominently on mature neutrophils, eosinophils, and monocytes, CD15 serves as an important marker in immunophenotyping.
Conducted via immunohistochemistry or flow cytometry on blood, bone marrow, or tissue biopsies, this test is critical for diagnosing Classical Hodgkin Lymphoma, where CD15 is typically positive on characteristic Reed-Sternberg cells. It also aids in identifying granulocytic differentiation in Acute Myeloid Leukemia (AML). Evaluating CD15 expression assists clinicians in accurate cancer subtyping, staging, and determining optimal targeted therapies.
